Cardinal Health, Inc.
CAHCardinal Health is a volume driven distributor that survives on scale, efficiency, and the non stop demand for healthcare.
Because even a 1 percent operating margin can be powerful if it sits on top of enormous, recurring revenue.
Business Model
Drug and supply distribution
It buys pharmaceuticals and medical supplies in bulk and delivers them to pharmacies and hospitals.
Economic Engine
Scale over margin
Huge revenue volume turns tiny margins into meaningful profit and cash.
Long-Term Lens
Margin durability
The key question is whether it can defend its 1.0 percent operating margin over decades.
On this page
Company Story
How do Cardinal Health, Inc.'s business model and economics hold up on a closer read?
Start with the business itself, then go one layer deeper into the model, the economics, and the long-term case.
“A scale driven healthcare distributor with thin margins but durable demand, if it can protect its sliver of profit in a brutal pricing world.”
What does Cardinal Health, Inc. actually do?
Cardinal Health distributes prescription drugs and medical products to healthcare providers.
- Ships branded and generic drugs to pharmacies and hospitals
- Supplies medical and surgical products to healthcare facilities
- Operates large logistics and inventory management networks
Why it matters
Healthcare runs on logistics
Without reliable distributors, hospitals and pharmacies would struggle to keep life saving medicines in stock.
How does Cardinal Health, Inc. make money?
It earns a small markup on each product it distributes, making money through scale and efficiency.
- Gross margin is just 3.7 percent on products sold
- Operating margin is 1.0 percent after expenses
- Free cash flow is 1.19 times net income, showing strong cash conversion
Economic clue
Thin margins, big volume
The business depends on moving massive amounts of product, because each dollar of sales produces less than a penny of net profit.
Why do long-term investors keep Cardinal Health, Inc. on the radar?
Healthcare demand is steady and growing, which gives distributors like Cardinal Health a long runway.
- Five year average revenue growth is 8.2 percent
- Five year average earnings per share growth is 32.7 percent
- Nearly 48,000 employees support a national logistics footprint
Investor takeaway
Scale plus stability
If healthcare spending keeps rising over decades, a scaled distributor can compound steadily even without flashy margins.
Based on company financial statements.
Benchmark Comparison
How has Cardinal Health, Inc. performed against common long-term benchmarks?
Once the business case is clear, compare the stock against broad market and alternative long-term baselines.
$4,071
+307.1% total return
$1,753
+75.3% total return
$2,975
+197.5% total return
$1,393
+39.3% total return
| Asset | Total Return | Dollar Value |
|---|---|---|
| CAH | +307.1% | $4,071 |
| S&P 500 | +75.3% | $1,753 |
| Gold | +197.5% | $2,975 |
| Bitcoin | +39.3% | $1,393 |
From Mar 5, 2021 to Mar 6, 2026. Historical price data based on company financial statements and market indices. Each card uses the same starting amount so the comparison stays apples-to-apples.
Investor Fit
How a first-time investor could frame Cardinal Health, Inc.
Before going deeper, decide what kind of business this is, what it tends to suit, and what deserves monitoring over time.
This Can Fit If You Want
- Exposure to long term healthcare demand without betting on one drug
- A business that converts earnings into real cash at 1.19 times net income
- Steady compounding driven by scale rather than innovation breakthroughs
Be Careful If You Expect
- High profit margins, since net margin is only 0.7 percent
- Rapid top line growth, with recent revenue down 1.9 percent year over year
- A wide competitive moat based on brand or technology
What To Watch Over Time
- Whether operating margin holds near 1.0 percent or keeps contracting
- Free cash flow staying above net income
- Disciplined buybacks like the 0.8 billion dollars repurchased in the last 12 months
Key Metrics
Which metrics matter most for Cardinal Health, Inc. right now?
Three durable business metrics that matter more than day-to-day price moves.
8.2% average annual growth (5Y)
32.7% average annual growth (5Y)
3.7% gross margin
| Metric | Value | Context |
|---|---|---|
| Revenue Growth | 8.2% average annual growth (5Y) | Shows whether the business has been expanding fast enough to create more long-term value. |
| EPS Growth | 32.7% average annual growth (5Y) | Shows whether earnings per share are compounding for owners over time. |
| Margin Quality | 3.7% gross margin | Shows how much room the business has to fund growth, absorb shocks, and stay profitable. |
Based on company financial statements.
Fundamentals
What do Cardinal Health, Inc.'s fundamentals say right now?
Core financial markers that explain how the business is performing beneath the stock price.
-16.6% ROIC
3.7% gross margin
0.8% FCF margin
Stable to shrinking
| Metric | Value | Interpretation |
|---|---|---|
| Capital Efficiency | -16.6% ROIC | The business is currently showing poor capital efficiency. |
| Profitability | 3.7% gross margin | Healthy gross margins give the company room to invest, price competitively, and absorb shocks. |
| Cash Generation | 0.8% FCF margin | Free cash flow margin shows how much real cash the business keeps after funding operations and investment. |
| Ownership Trend | Stable to shrinking | The company is not currently diluting owners and may be buying back shares instead. |
Based on company financial statements.
Included In Funds
Which ETFs and funds currently hold Cardinal Health, Inc.?
Cardinal Health, Inc. currently appears in these ETF and fund proxies.
SPY
SPDR S&P 500 ETF Trust
IWB
iShares Russell 1000 ETF
Questions & Answers
What questions come up most often about Cardinal Health, Inc.?
Company-specific questions readers often ask about Cardinal Health, Inc..
Each entry answers a direct question about the business, the long-term thesis, or the risks that matter over time.
Cardinal Health distributes prescription drugs and medical supplies from manufacturers to pharmacies, hospitals, and clinics.
Decision Framing
Secondary context after the long-term thesis
Shorter-horizon context and comparison tools, after the core long-term read.
Shorter-horizon price moves, two-sided debate, and comparison tools live here so the page stays anchored on business quality, durability, and BinaPrint fit first.
Investment Thesis
Bull vs Bear
Two-sided framing before any decision.
Current argument weight is balanced.
Bull case
What can work
Healthcare demand is structurally rising due to aging populations and chronic disease, which supports steady volume growth for distributors over decades.
Scale advantages in warehousing and transportation create cost efficiencies that smaller competitors struggle to match, helping defend the 1.0 percent operating margin.
Strong cash conversion, with free cash flow at 1.19 times net income, allows consistent buybacks and debt management.
Five year average earnings per share growth of 32.7 percent shows that even in a low margin model, disciplined cost control and share repurchases can drive owner returns.
Bear case
What can break
Extreme price competition could compress gross margin below 3.7 percent, and with only 0.7 percent net margin, even small cuts could slash profits.
Regulatory changes in drug pricing or reimbursement could squeeze distributor spreads and structurally lower profitability.
Large customers like national pharmacy chains may gain bargaining power and demand lower fees, eroding the already thin 1.0 percent operating margin.
Disintermediation risk exists if manufacturers or large buyers build direct distribution capabilities, bypassing traditional wholesalers.
Risk Radar
Key Risks
Where downside pressure can build.
Margin compression, with net margin at only 0.7 percent, meaning a 0.3 percent drop could materially reduce profits.
Revenue volatility, with recent year over year revenue down 1.9 percent despite five year average growth of 8.2 percent.
High fixed cost logistics network, with 0.5 billion dollars in annual capital spending required to maintain infrastructure.
Sizing matters
Risks should be read as scenario inputs, not certainties. Position size and time horizon determine how much of this downside profile is acceptable.
Market Snapshot
Tactical context after the core long-term read.
- Price
- $217.78
- Daily move
- +0.81%
Peer Set
A compact peer list for side-by-side context.
Next Actions
Explore planning scenarios or keep browsing similar companies.